Phase 3 trial of Ibrutinib plus rituximab in Waldenstrom's macroglobulinemia

M. A. Dimopoulos, A. Tedeschi, J. Trotman, R. Garcia-Sanz, D. Macdonald, V. Leblond, B. Mahe, C. Herbaux, C. Tam, L. Orsucci, M. L. Palomba, J. V. Matous, C. Shustik, E. Kastritis, S. P. Treon, J. Li, Z. Salman, T. Graef, C. Buske

Research output: Contribution to journal › Article › peer-review